Edition:
United States

Sonoma Pharmaceuticals announces FDA approval of expanded indication for Alevicyn


Thursday, 16 Nov 2017 07:45am EST 

Nov 16 (Reuters) - Sonoma Pharmaceuticals Inc ::Announces FDA approval of expanded indication for Alevicyn to add antimicrobial language.Approved Alevicyn dermal spray, to include antimicrobial language and antimicrobial data against clinically relevant microorganisms​. 

Company Quote

1.105
-0.095 -7.92%
16 Nov 2018